Glucosamine + Methylsulphonylmethane + Perna Canaliculus + Manganese + Dimethylglycine

12 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

830.0%

Death Rate

Active Ingredients

Glucosamine + Methylsulphonylmethane + Perna Canaliculus + Manganese + Dimethylglycine

Administration Routes

OralUnknown

Species Affected

Dog 10

Cat 2

Most Affected Breeds

Retriever - Labrador 2

Chihuahua 1

Lhasa Apso 1

Terrier - Yorkshire 1

Maltese 1

Maine Coon 1

Domestic Shorthair 1

Hound - Basset 1

Dog (other) 1

Shepherd Dog (unspecified) 1

Most Reported Reactions

Emesis 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Vomiting 3

Elevated alanine aminotransferase (ALT) 2

Emesis (multiple) 1

Cough 1

Lack of efficacy (flea) 1

Skin and/or appendage neoplasm NOS 1

Anorexia 1

Elevated serum alkaline phosphatase (SAP) 1

Hypokalaemia 1

Elevated total bilirubin 1

Outcome Breakdown

Recovered/Normal

6 (50.0%)

Outcome Unknown

2 (16.7%)

Ongoing

2 (16.7%)

Recovered with Sequela

1 (8.3%)

Euthanized

1 (8.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.